Vycor Medical Inc (VYCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90 | 77 | 102 | 206 | 315 |
| Receivables | 245 | 136 | 131 | 110 | 238 |
| Inventories | 218 | 182 | 201 | 214 | 212 |
| TOTAL | $654 | $472 | $552 | $609 | $853 |
| Non-Current Assets | |||||
| PPE Net | 446 | 474 | 470 | 489 | 503 |
| Investments And Advances | 6 | 7 | 8 | 9 | 9 |
| Intangibles | 305 | 317 | 330 | 343 | 376 |
| TOTAL | $756 | $798 | $808 | $841 | $887 |
| Total Assets | $1,410 | $1,270 | $1,360 | $1,450 | $1,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 96 | 118 | 130 | 141 | 174 |
| Accrued Expenses | 1,194 | 906 | 1,146 | 908 | 818 |
| TOTAL | $1,830 | $1,510 | $1,650 | $1,368 | $1,328 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,830 | $1,510 | $1,650 | $1,368 | $1,328 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,605 | 22,217 | 21,876 | 20,072 | 19,817 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -28,188 | -27,873 | -27,455 | -26,966 | -26,591 |
| Other shareholders' equity | 127 | 126 | 123 | 124 | 124 |
| TOTAL | $-420 | $-240 | $-290 | $81 | $412 |
| Total Liabilities And Equity | $1,410 | $1,270 | $1,360 | $1,449 | $1,740 |